Luminex Profit Margin 2006-2019 | LMNX

Current and historical gross margin, operating margin and net profit margin for Luminex (LMNX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Luminex net profit margin as of September 30, 2019 is -2.93%.
Luminex Annual Profit Margins
Luminex Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.044B $0.316B
Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $136.012B 28.17
Intuitive Surgical (ISRG) United States $69.348B 54.50
Edwards Lifesciences (EW) United States $49.773B 45.20
IDEXX Laboratories (IDXX) United States $24.517B 59.29
Fresenius Medical Care AG KGaA (FMS) Germany $22.773B 15.41
Olympus (OCPNY) Japan $22.330B 0.00
DexCom (DXCM) United States $21.124B 189.17
Teleflex (TFX) United States $17.765B 36.06
SONOVA HOLDING (SONVY) Switzerland $15.277B 0.00
Sysmex ADR (SSMXY) Japan $14.597B 39.29
Hologic (HOLX) United States $14.566B 22.26
Varian Medical Systems (VAR) United States $13.545B 32.11
STERIS (STE) Ireland $13.068B 28.86
Masimo (MASI) United States $9.053B 54.06
ABIOMED (ABMD) United States $8.186B 44.54
SARTORIUS AG (SARTF) Germany $6.731B 59.08
Penumbra (PEN) United States $5.599B 182.23
Globus Medical (GMED) United States $5.299B 32.70
Integra LifeSciences Holdings (IART) United States $5.077B 21.82
Elekta AB (EKTAY) Sweden $4.535B 38.29
Tandem Diabetes Care (TNDM) United States $4.053B 0.00
Wright Medical Group (WMGI) Netherlands $3.820B 231.54
Nevro (NVRO) United States $3.752B 0.00
LivaNova (LIVN) United Kingdom $3.547B 25.53
Integer Holdings (ITGR) United States $2.909B 19.92
Cantel Medical (CMD) United States $2.659B 26.02
Nihon Kohden (NHNKY) Japan $2.458B 24.73
Glaukos (GKOS) United States $2.088B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.588B 31.26
Veracyte (VCYT) United States $1.473B 0.00
Silk Road Medical (SILK) United States $1.322B 0.00
Natus Medical (NTUS) United States $1.170B 28.14
Mesa Laboratories (MLAB) United States $1.159B 42.97
Tactile Systems Technology (TCMD) United States $1.157B 132.22
CryoLife (CRY) United States $1.125B 115.35
Inogen (INGN) United States $1.087B 34.33
OPKO Health (OPK) United States $1.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.945B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.894B 29.71
OrthoPediatrics (KIDS) United States $0.799B 0.00
Intersect ENT (XENT) United States $0.771B 0.00
Pacific Biosciences Of California (PACB) United States $0.762B 0.00
Quotient (QTNT) Switzerland $0.686B 0.00
AngioDynamics (ANGO) United States $0.582B 26.69
AxoGen (AXGN) United States $0.565B 0.00
Si-Bone (SIBN) United States $0.544B 0.00
Alphatec Holdings (ATEC) United States $0.456B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.427B 12.92
Sientra (SIEN) United States $0.379B 0.00
Semler Scientific (SMLR) United States $0.327B 45.46
RTI Surgical (RTIX) United States $0.326B 88.20
ViewRay (VRAY) United States $0.310B 0.00
SeaSpine Holdings (SPNE) United States $0.303B 0.00
IRadimed (IRMD) United States $0.301B 42.34
Fluidigm (FLDM) United States $0.294B 0.00
Accuray (ARAY) United States $0.292B 0.00
GenMark Diagnostics (GNMK) United States $0.288B 0.00
Restoration Robotics (VERO) Canada $0.171B 0.00
Spectral Diagnostics (EDTXF) Canada $0.127B 0.00
EDAP TMS S.A (EDAP) France $0.119B 31.54
ConforMIS (CFMS) United States $0.087B 0.00
Neuronetics (STIM) United States $0.082B 0.00
Vermillion (VRML) United States $0.078B 0.00
Second Sight Medical Products (EYES) United States $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.070B 0.00
Bioanalytical Systems (BASI) United States $0.063B 0.00
Apollo Endosurgery (APEN) United States $0.060B 0.00
T2 Biosystems (TTOO) United States $0.055B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.038B 0.00
Helius Medical Technologies (HSDT) United States $0.034B 0.00
Neovasc (NVCN) Canada $0.029B 0.00
Ekso Bionics Holdings (EKSO) United States $0.027B 0.00
Ra Medical Systems (RMED) United States $0.023B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
ReWalk Robotics (RWLK) Israel $0.016B 0.00
ENDRA Life Sciences (NDRA) United States $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.015B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.012B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00